Cell-basedAssay Market, By Product (Cell Lines, Microplates, Instruments, Software,Reagents and Assay Kits and Others), By Application (Drug Discovery, PredictiveToxicology, ADME Process and Others), By End-User (Pharmaceutical Companies,Biotechnology Companies, Research Organizations, Government & Academic Institutesand Others) and Geography– Global Industry Insights, Trends, Outlook, andOpportunity Analysis, 2026
Cell-based assay refers toexperiments based on living cells and is an influential tool in the researchlab. Cell-based assays are vital for understanding cellular mechanism in abiological context as these assays provide information about intracellularmolecular targets. There are variety of assays used to measure motility,toxicity, cell proliferation, production of a measurable product, andmorphology. Cell-based assays provides accuracy in obtaining the data ofvarious parameters of the real-life model as live cells are used, cell-basedassays are now used in drug discovery and checking the toxicity of new or olddrugs used by population. With the rapid growth of pharmaceutical and biotechnologicalsector worldwide and emerging development of new drugs, the demand forcell-based assay is expected to witness a rapid increase. Companies areadopting the cell-based assay order to reverse the costly late-stage drugfailure and thus the rising surge of cell-based assay is expect to have apositive effect on market growth in near future.
* The sample copy includes: Report Summary, Table ofContents, Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/1273
Cumulative growth in drugdiscovery is expected to boost cell-based assay market in forecast period
Rapid growth in drug discovery isexpected to increase the demand for cell-based assay as it is mainly used inchecking toxicity of drugs. For instance according to FDA’s Center for DrugEvaluation and Research (CDER) in 2016, CDER approves averagely 30 novel drugsper year and the development of novel drug discovery is expected to increase infuture. Many companies are involved in the drug discovery needs cell-basedassay for testing new drugs that is expected to boost the cell-based assaymarket in forecast period. Since pharmaceutical market have become a billion-dollarbusiness, many pharmaceutical and biotechnological companies are adoptingcell-based assay in order to reduce the chances of failure of batch which leadto a high loss to company. Thus, the adoption of this method by companies isexpected to fuel its market in near future. However, high maintenance, need forskilled personnel and high-cost of operation for the cell based assays areexpected to hinder the market growth.
Browse ResearchReport: https://www.coherentmarketinsights.com/ongoing-insight/cell-based-assay-market-1273
North America is expected todominate cell-based assay market due to growing pharmaceutical sector in region
Regional segmentation ofcell-based assay market by Coherent Market Insights includes North America,Latin America, Europe, Asia Pacific, Middle East and Africa. North America isexpected to hold a dominant position in the cell-based assay market due torapid growth of pharmaceutical and biotechnology manufacturing sector.According to a study published in International Trade Administration in 2016,U.S. is a major hub for drug manufacturing and the market is expected to growdrastically in future which is expected to fuel cell-based assay market inNorth America. Asia pacific is expected to follow North America market inupcoming period of time due to increase in pharmaceutical and biotechnologicalsector in China and India which will increase the demand for cell-based assayand fuel its market in forecast period.
DiscoverX Corporation launchedin-cell pulse cell-based assays for confirmation of compound-target engagementin drug discovery
Major key players in cell-basedassay market are DiscoverX Corporation, Becton, Dickinson and Company, cellSignaling Technology, Inc., Becton, Danaher Corporation, Thermo FisherScientific, Inc., Cisbio Bioassays, Merck & Co., and PerkinElmer, Inc. andothers. DiscoverX Corporation, one of the leading supplier of cell-based assayin 2016 introduced InCELL Pulse target engagement platform that providesscientists with the ability to generate their own cell-based target engagementassays for confirming compound cell entry and target binding in the nativecellular environment.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/1273
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollar opportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN: +050-5539-1737
